Harper Molly's most recent trade in Catalyst Pharmaceuticals Inc was a trade of 1,334 Restricted Stock Units done . Disclosure was reported to the exchange on Dec. 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2025 | 1,334 | 127,163 | - | - | Restricted Stock Units | |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2025 | 1,334 | 3,694 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 20,000 | 128,497 | - | - | Options to purchase common stock | |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.78 per share. | 12 Dec 2025 | 20,000 | 29,106 (0%) | 0% | 5.8 | 115,600 | Common stock, par value $0.001 per share |
| Catalyst Pharma Inc | Molly Harper | Director | Sale of securities on an exchange or to another person at price $ 23.20 per share. | 12 Dec 2025 | 15,527 | 13,579 (0%) | 0% | 23.2 | 360,195 | Common stock, par value $0.001 per share |
| Catalyst Pharma Inc | Molly Harper | Director | Sale of securities on an exchange or to another person at price $ 23.06 per share. | 12 Dec 2025 | 6,746 | 2,360 (0%) | 0% | 23.1 | 155,563 | Common stock, par value $0.001 per share |
| Catalyst Pharma Inc | Molly Harper | Director | Sale of securities on an exchange or to another person at price $ 23.73 per share. | 12 Dec 2025 | 4,473 | 9,106 (0%) | 0% | 23.7 | 106,162 | Common stock, par value $0.001 per share |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 1,413 | 148,497 | - | - | Restricted Stock Units | |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 1,413 | 9,106 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharma Inc | Molly Harper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 18,115 | 145,389 | - | - | Options to purchase common stock | |
| Catalyst Pharma Inc | Molly Harper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 5,468 | 150,857 | - | - | Restricted Stock Units | |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 947 | 149,910 | - | - | Restricted Stock Units | |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 947 | 7,693 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 4,000 | 127,274 | - | - | Restricted Stock Units | |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 4,000 | 6,746 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 1,333 | 131,274 | - | - | Restricted Stock Units | |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 1,333 | 2,746 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 1,413 | 132,607 | - | - | Restricted Stock Units | |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 1,413 | 1,413 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.78 per share. | 27 Nov 2024 | 17,500 | 17,500 (0%) | 0% | 5.8 | 101,150 | Common stock, par value $0.001 per share |
| Catalyst Pharma Inc | Harper Molly | Director | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 27 Nov 2024 | 17,500 | 0 (0%) | 0% | 22 | 385,000 | Common stock, par value $0.001 per share |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 17,500 | 134,020 | - | - | Options to purchase common stock | |
| Catalyst Pharma Inc | Molly Harper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 23,248 | 148,679 | - | - | Options to purchase common stock | |
| Catalyst Pharma Inc | Molly Harper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 2,841 | 151,520 | - | - | Restricted Stock Units | |
| Catalyst Pharma Inc | Molly Harper | Director | Sale of securities on an exchange or to another person at price $ 16.30 per share. | 03 Jun 2024 | 5,333 | 0 (0%) | 0% | 16.3 | 86,949 | Common Stock, par value $0.001 per share |
| Catalyst Pharma Inc | Harper Molly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 4,000 | 5,333 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharma Inc | Harper Molly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 4,000 | 125,431 | - | - | Restricted Stock Units | |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2023 | 1,333 | 129,431 | - | - | Restricted Stock Units | |
| Catalyst Pharma Inc | Harper Molly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2023 | 1,333 | 1,333 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.78 per share. | 15 Dec 2023 | 10,000 | 10,000 (0%) | 0% | 5.8 | 57,800 | Common stock, par value $0.001 per share |
| Catalyst Pharma Inc | Molly Harper | Director | Sale of securities on an exchange or to another person at price $ 14.37 per share. | 15 Dec 2023 | 10,000 | 0 (0%) | 0% | 14.4 | 143,700 | Common stock, par value $0.001 per share |
| Catalyst Pharma Inc | Harper Molly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 10,000 | 130,764 | - | - | Options to purchase common stock | |
| Catalyst Pharma Inc | Harper Molly | Director | Sale of securities on an exchange or to another person at price $ 14.43 per share. | 15 Dec 2023 | 4,000 | 0 (0%) | 0% | 14.4 | 57,720 | Common stock, par value $0.001 per share |
| Catalyst Pharma Inc | Harper Molly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 29,524 | 136,524 | - | - | Options to purchase common stock | |
| Catalyst Pharma Inc | Harper Molly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 4,240 | 140,764 | - | - | Restricted Stock Units | |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 4,000 | 4,000 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 4,000 | 107,000 | - | - | Restricted Stock Units | |
| Catalyst Pharma Inc | Molly Harper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2022 | 15,000 | 107,000 | - | - | Options to purchase common stock | |
| Catalyst Pharma Inc | Molly Harper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2022 | 4,000 | 111,000 | - | - | Restricted Stock Units | |
| Catalyst Pharma Inc | Molly Harper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 12,000 | 92,000 | - | - | Restricted Stock Units | |
| Catalyst Pharma Inc | Molly Harper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2021 | 20,000 | 80,000 | - | - | Options to purchase common stock |